351 related articles for article (PubMed ID: 17261306)
1. Selective COX-2 inhibitors: a promise unfulfilled?
Henry D; McGettigan P
Gastroenterology; 2007 Feb; 132(2):790-4. PubMed ID: 17261306
[No Abstract] [Full Text] [Related]
2. [NSAID therapy. Gastrointestinal risks of classic NSAID are underestimated].
MMW Fortschr Med; 2010 May; 152(20):46-7. PubMed ID: 20552882
[No Abstract] [Full Text] [Related]
3. [Nonsteroidal anti-inflammatory agents--choice between disturbances of gastrointestinal tract and cardiovascular toxicity].
Gumbrevicius G; Milasius A; Sveikata A
Medicina (Kaunas); 2006; 42(5):429-39. PubMed ID: 16778472
[TBL] [Abstract][Full Text] [Related]
4. [Pathogen eradication prevents gastrointestinal complications].
MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
[No Abstract] [Full Text] [Related]
5. Introduction of newer selective cyclo-oxygenase-2 inhibitors and rates of hospitalization with bleeding and perforated peptic ulcer.
Christensen S; Riis A; Nørgaard M; Thomsen RW; Sørensen HT
Aliment Pharmacol Ther; 2007 Apr; 25(8):907-12. PubMed ID: 17402994
[TBL] [Abstract][Full Text] [Related]
6. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
7. [Frequency and severity of gastric and duodenal lesions induced by non-steroidal anti-inflammatory agents and aspirin].
Florent C; Desaint B
Gastroenterol Clin Biol; 1989 Mar; 13(3):235-8. PubMed ID: 2731675
[No Abstract] [Full Text] [Related]
8. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
García Rodríguez LA; Barreales Tolosa L
Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
Patterson MK; Castellsague J; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705
[TBL] [Abstract][Full Text] [Related]
10. [Safety of selective cyclooxygenase-2 inhibitors taken for a long time].
Lamarque D
Bull Cancer; 2004 May; 91 Suppl 2():S117-24. PubMed ID: 15899636
[TBL] [Abstract][Full Text] [Related]
11. [Non-steroid anti-inflammatory agents and digestive tract lesions].
Lanas Arbeloa AI; Hirschowitz BI
Rev Esp Enferm Dig; 1993 Nov; 84(5):326-35. PubMed ID: 8305260
[No Abstract] [Full Text] [Related]
12. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.
Lanas A; Baron JA; Sandler RS; Horgan K; Bolognese J; Oxenius B; Quan H; Watson D; Cook TJ; Schoen R; Burke C; Loftus S; Niv Y; Ridell R; Morton D; Bresalier R
Gastroenterology; 2007 Feb; 132(2):490-7. PubMed ID: 17258718
[TBL] [Abstract][Full Text] [Related]
13. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
[No Abstract] [Full Text] [Related]
14. Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications.
Lanas A
Postgrad Med; 2005 Jun; 117(6):23-8, 31. PubMed ID: 16001765
[TBL] [Abstract][Full Text] [Related]
15. The role of endoscopy in the management of patients with peptic ulcer disease.
; Banerjee S; Cash BD; Dominitz JA; Baron TH; Anderson MA; Ben-Menachem T; Fisher L; Fukami N; Harrison ME; Ikenberry SO; Khan K; Krinsky ML; Maple J; Fanelli RD; Strohmeyer L
Gastrointest Endosc; 2010 Apr; 71(4):663-8. PubMed ID: 20363407
[No Abstract] [Full Text] [Related]
16. The epidemiology of NSAID associated gastrointestinal disease.
Wolfe F
Eur J Rheumatol Inflamm; 1991; 11(3):12-28. PubMed ID: 1365476
[TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
Thiéfin G
Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
[No Abstract] [Full Text] [Related]
18. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
McColl KE
Gastroenterol Clin North Am; 2009 Jun; 38(2):353-61. PubMed ID: 19446263
[TBL] [Abstract][Full Text] [Related]
19. [Drug-induced hemorrhages of the gastrointestinal tract].
Berndt H
Z Arztl Fortbild (Jena); 1983; 77(12):503-6. PubMed ID: 6603719
[No Abstract] [Full Text] [Related]
20. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
